Biomedical subjects

P K Weng

Publications and source records attributed to P K Weng.

3 recordsLinked to original sources

PubMed2000

Immunolocalization of inducible nitric oxide synthase and 3-nitrotyrosine in the nasal mucosa of patients with rhinitis.

Since nitric oxide (NO) can be involved in multiple physiological and pathological functions, we evaluated its possible involvement and that of peroxynitrite in the pathogenesis of rhinitis. Inferior nasal turbinates were obtained from allergic rhinitis and nonallergic rhinitis patients during corrective nasal surgery. The expressions of the inducible form of nitric oxide synthase (iNOS) and the production of peroxynitrite and its metabolite 3-nitrotyrosine were examined by immunohistochemistry in consecutive tissue sections. Each section (or tissue compartment) was given a score of 0-4 according to the labeling intensity seen, with the highest number representing the highest labeling intensity. The results showed that iNOS expression was present mainly in the mucosal epithelium, vascular endothelium, and submucosal glands. A significant difference was only observed in the labeling scores of glandular tissues of the allergic group, which had a higher iNOS labeling score. We also found that sections with a higher iNOS level did not necessarily exhibit a higher 3-nitrotyrosine labeling intensity. These data suggest that iNOS-derived NO may have a role in the pathophysiology of rhinitis, especially the glandular function of allergic nasal mucosa. Moreover, our findings suggest that the production of peroxynitrite in rhinitis patients is not dependent on the level of iNOS alone.

Adolescent↗

PubMed2000

Computerized rotational vestibular testing in normal subjects.

BACKGROUND: As an integral part of the contemporary vestibular testing battery, computerized vestibular rotational testing provides physiologic stimuli and quantitative evaluation of the vestibulo-ocular reflex function of the horizontal semicircular canals. Clinically, it is most commonly used in the sinusoidal harmonic acceleration test (SHAT) and velocity step test. Because the results for a given subject may vary when tested using different facilities, the purpose of this study is to establish the normative data for our laboratory. METHODS: Fifty-six normal subjects underwent the SHAT and velocity step test. Three parameters of SHAT--gain, phase and symmetry--were measured and recorded at 0.02, 0.05, 0.09 and 0.10 Hz. In the velocity step test, the three parameters of postrotatory nystagmus-time constant, maximum slow component eye velocity and directional preponderance were measured and recorded. RESULTS: The means +/- standard deviations of gain in the SHAT were 0.47 +/- 0.16 at 0.02 Hz, 0.50 +/- 0.16 at 0.05 Hz, 0.50 +/- 0.16 at 0.09 Hz and 0.53 +/- 0.17 at 0.10 Hz. The coefficient of variation for SHAT gain was 0.32. The time constant means and standard deviations in the velocity step test were 13.44 +/- 3.53 and 13.52 +/- 3.69 for clockwise and counterclockwise rotations, respectively. CONCLUSIONS: We conclude that computerized rotational vestibular testing is precise.

Adolescent↗

PubMed1997

Late-onset life-threatening angioedema and upper airway obstruction caused by angiotensin-converting enzyme inhibitor: report of a case.

Angioedema is a rare but potentially lethal adverse effect when associated with upper airway obstruction. Sporadic cases of angioedema secondary to angiotensin converting enzyme inhibitors (ACEI) have been reported in the literature. The overall incidence is around 0.1% to 0.2%, and the time of onset is usually during the first week of ACEI therapy. Late-onset angioedema secondary to treatment with ACEIs is much more frequent than appreciated, and is largely unrecognized because of the absence of temporal correlation between ACEI therapy and the development of angioedema. Since angioedema may progress to upper airway obstruction, otolaryngologists must be aware of this association. Most importantly, late-onset angioedema should alert the clinician to discontinue the ACEI immediately to prevent further morbidity. This report presents an example of late-onset angioedema which was precipitated by taking a double dose of captopril incidentally. The case is discussed, and the literature, pathophysiology and treatment of angioedema are reviewed.

Age of Onset↗